论文部分内容阅读
夺去甲氧柔红霉素（IDA）是柔红霉素的衍生物。研究表明在急性白血病治疗中具有疗效高、毒性低等优点“’，尤其是对难治性和复发性白血病具有较高的缓解率”’。我们采用IDA联合阿糖胞着（Ara－C）治疗17例次难治性和复发性白血病，结果如厂。工材料和方法1．1病例难治性白血?
Abrogation of idarubicin (IDA) is a derivative of daunorubicin. Studies have shown that it has advantages such as high efficacy and low toxicity in the treatment of acute leukemia, especially for refractory and relapsed leukemia. We used IDA combined with Ara-C to treat 17 cases of refractory and relapsed leukemia. Materials and Methods 1.1 Cases of refractory white blood?